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Background: This study investigated the type and frequency of procedure-related adverse events among those enrolled in the MADIT-CRT and 
identified clinical predictors for gender-specific events.
Methods: 444 Females and 1,346 males were enrolled in MADIT-CRT. We compared differences in the rate of procedure-related adverse events by 
gender that occurred ≤ 30 days after the index procedure in the ICD and CRT therapy groups. Eight types of major adverse events were identified; 
defined as procedure-related complications deemed potentially life-threatening or requiring re-operation. Best subset regression analysis (P<0.10) 
was performed to identify baseline clinical factors associated with procedure-related adverse events that differ by gender.
Results: Women randomized to the CRT-D treatment arm received a greater reduction in the risk of heart failure or death versus those in the ICD-
only arm compared to men (p<0.001). However, women were 2.25 times more likely than men to experience a major procedure-related adverse 
event as a result of ICD or CRT therapy (6.8% vs. 3.1%; P=0.001), including pneumothorax/ hemothorax (4% vs. 1%; P<0.001). Women were more 
likely to experience a major adverse event related to CRT than to ICD implantation (9.2% vs. 2.9%; P=0.010). The clinical predictors of any major 
event in females were smaller body mass index (BMI), elevated blood urea nitrogen, and elevated creatinine; the clinical predictors in males 
were elevated systolic blood pressure, current smoking, New York Heart Association (NYHA) Class II, QRS duration >150ms, history of ventricular 
arrhythmia, and diabetes. The predictor for pneumothorax/ hemothorax was reduced BMI for women and men
Conclusions: Women demonstrate greater clinical benefit from CRT than men but are more likely to experience adverse procedure-related events 
within the first 30 days after device implantation. A smaller BMI seems to be a major factor associated with pneumothorax/hemothorax in both 
females and males.
